Diastat AcuDial

Shares of Acorda Therapeutics Inc (NASDAQ: ACOR) were trading lower by 2 percent early Friday, but have since recovered most of the losses. The brief selloff occurred in reaction to the company's announcement that it will discontinue development for its Nasal Spray called Plumiaz. Plumiaz...